• OPEN AN ACCOUNT
Indian Indices
Sensex
73,895.74 315.20
( 0.43%)
Global Indices
Nasdaq
51,839.66 468.68
(0.91%)
Dow Jones
7,763.25 38.12
(0.49%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.89 0.16
(0.16%)
EUR-INR
109.08 -0.12
(-0.11%)
GBP-INR
126.82 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
139.68
444716.74
EPS(TTM)
Face Value()
Div & Yield %
13.27
1
0.86
 

bn holdings ltd
Khoobsurat reports standalone net loss of Rs 4.70 crore in the March 2026 quarter
Jun 01,2026
Net Loss of Khoobsurat reported to Rs 4.70 crore in the quarter ended March 2026 as against net loss of Rs 0.60 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.47 crore in the year ended March 2026 as against net loss of Rs 2.22 crore during the previous year ended March 2025. Sales reported to Rs 0.34 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.